NanoMosaic
NanoMosaic is a biotechnology company delivering ultra-sensitive multiomics powered by its NanoNeedle single-molecule detection technology, purpose-built for gene therapy analytics, neurology biomarkers, and brain health research. Its FDA/CBER AMT-designated AAV analytics platform supports high-sensitivity protein and biomarker quantification for therapeutics developers. Backed by Insight Partners, the company is profiled in the API Evangelist network; it operates a corporate web presence and publishes no public API, developer platform, or SDK.
NanoMosaic is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Proteomics, Multiomics, and Gene Therapy.
NanoMosaic’s developer surface includes support, engineering blog, and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 3
The organization behind the API